# 68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers

> **NCT05346276** · — · COMPLETED · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 50 (actual)

## Conditions studied

- PET/CT
- hLAG-3
- TUMOR

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-DOTA-hLAG-3 PET/CT

## Key facts

- **NCT ID:** NCT05346276
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-10
- **Primary completion:** 2024-12-13
- **Final completion:** 2024-12-13
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05346276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05346276, "68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05346276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*